Pune, India, 2022, MRFR Press Release/- Market Research Future has published a Cooked Research Report on the Global Metabolomics Services Market.
Metabolomics Services Market is expected to register a CAGR of 11.92% during the forecast period with a market value of USD 6.36 Billion till 2030.
Metabolomics services have been growing at a rapid pace over the last few years. Metabolomics services provide information about the metabolic phenotype by identifying and quantifying the biochemical byproducts of metabolism using different technologically advanced products.
The major key factors driving the market growth are the growing prevalence of diseases such as cancer, neurological disorders, and cardiac diseases across the globe, technological advancements in instrumentation, and increasing application of metabolomics in the life science and biotechnological industry. However, factors such as high cost of instruments and stringent government policies/regulations may hamper the market growth.
The Global Metabolomics Services Market is segmented into product and service and application. Based on product and service, the market has been segmented into chromatography, metabolomics bioinformatics services, and mass spectrometry. On the basis of application, the global metabolomics services market has been segmented into biomedical and pharmaceutical, agriculture, and food.
Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Metabolomics Services Market Research Report
The Global Metabolomics Services Market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas are expected to hold the largest share of the global metabolomics services market. This is owing to the increasing patient population suffering from cancer, and cardiovascular diseases are boosting the market growth in this region.
The Europe market holds the second-largest position in the global metabolomics services market due to the presence of a large number of companies such as Biocrates Life Sciences AG (Biocrates), Bruker, Waters, and other providing metabolomics services drives the growth of the market in this region.
Asia-Pacific is estimated to be the fastest-growing region owing to a large number of patient population suffering from chronic disease and increasing demand for treatment for the same.
The metabolomics services market in the Middle East & Africa accounts for the least market share due to the adequate healthcare infrastructure support accounted for a relatively smaller market share in 2022.
MRFR recognizes the following companies as the Key Players in the Global Metabolomics Services Market—Agilent Technologies, Inc. (US), Waters (US), Bruker (US), TMIC (CANADA), Thermo Fisher Scientific (US), Biocrates Life Sciences AG (AUSTRIA), Creative Proteomics (US), Human Metabolome Technologies America Inc (JAPAN), Shimazdu Corporation (Japan), and Metabolon, INC (US)
Key Findings of the Study